The Relation Between Formulary Design and the PBM Business Model

Posted By

  The Effect of Corporate Structure on Formulary Design: The Case of Large Insurance Companies Poster Presentation, ISPOR 10th Annual Meeting, Washington DC, May 2005 The Role of Pharmacy Benefit Managers in Formulary Design: Service Providers or Fiduciaries? Journal of Managed Care Pharmacy Vol. 10 No. 4 July/August 2004 pp 359-60 The Formulary Game (07/03) Hepatitis […]

Feb 28,2018No Comments

Insulin Drug Price Inflation: Racketeering or Perverse Competition?

Posted By

Summary We contend that recent insulin drug price inflation is a case of perverse competition rather than a case of illegal racketeering in violation of the RICO Act.   We will present the case that a now consolidated racketeering RICO lawsuit initiated by the law firm Hagens Berman has inverted the hierarchy of the Pharma […]

Jan 21,2018No Comments


Posted By

I have a B.A. in Economics from Amherst College and a Ph.D. in Economics from Washington University in St. Louis.  I was born and raised in St. Louis, Missouri.  I now live in North Monterey County, California. My writings are at the intersection of economics, accounting,  financial analysis, and high tech.  I like to write […]

Dec 29,2017No Comments